Metabolic & Cardiometabolic
bariatric surgery causes durable long-term weight loss
In plain terms: Does bariatric surgery produce durable long-term weight loss vs non-surgical care?
Strong support Metabolic & Cardiometabolic
Part of: 🩺 bariatric / metabolic surgery
RefutedContestedStrong support
consensus score 1.00
Yes—surgery yields large weight loss sustained for 10-20yr far exceeding non-surgical care, though partial regain and procedure-dependent durability are real.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
20 support 0 contradict 0 tested null 0 mixed · 20 sources, 19 independent groups
What the evidence shows
Bariatric surgery produces large weight loss that lasts. The Swedish Obese Subjects study followed patients for up to twenty years, a ten-year sleeve-gastrectomy cohort saw mean BMI fall from 42, and pooled randomised data show about 19 percent weight loss sustained at seven years against about 11 percent with medical care. Partial regain is normal, and how much is lost depends on the procedure.
The evidence (33)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H, Swedish Obese Subjects Study Scientific Group 2004 · N Engl J Med | observational | supports | high | Swedish Obese Subjects study: obese adults (mean age 48, mean BMI 41) who chose gastric surgery versus contemporaneously matched, conventionally treated controls; 4,047 had reached 2 years and 1,703 ten years, with 74.5% attending the 10-year examination. Weight fell 23.4% at 2 years and 16.1% at 10 years in the surgery group while controls gained 0.1% and 1.6% (P<0.001 both points). Recovery from diabetes, high triglycerides, low HDL, hypertension and high uric acid favoured surgery; recovery from high cholesterol did not differ. Allocation was by patient choice, not randomisation. |
| Szewczyk J, Grzyb I, Smolinska A, Boloz M, Krawczyk P, Watek Z, Lysynkiewicz K, Haba S, Dapkiewicz E, Gasowski D 2026 · Cureus | observational | supports | low | A narrative review of literature published mainly between 2020 and 2025, found through PubMed/MEDLINE and Google Scholar searches, covering randomised trials, meta-analyses and observational studies. It reports that bariatric surgery, particularly sleeve gastrectomy and Roux-en-Y gastric bypass, 'induces substantial and sustained weight loss', while listing weight regain among the risks and concluding that 'further prospective studies are needed to better define the durability of its benefits'. The abstract gives no figure for how much weight is lost, or over how long. |
| Shalitin S, Phillip M, Yackobovitch-Gavan M 2026 · Obesity (Silver Spring) | observational | supports | moderate | Retrospective cohort of 1035 Israeli adolescents (70% female, median age about 18.6) who had bariatric surgery between 2010 and 2024; 977 of them had post-operative BMI data, median follow-up 5.8 years. Mean BMI fell from 44.7 to a low of 29.1 kg/m2 in males and from 42.7 to 30.0 in females, the largest drop coming at 1-3 years. Partial regain followed: at 10-15 years mean BMI was 31.4 in males and 35.0 in females, still far below where they started, though only 96 people had data that far out. Blood pressure, glucose, HbA1c, triglycerides, liver enzymes and uric acid also improved. |
| Susmallian S, Nikiforova I, Raziel A 2026 · Obes Surg | observational | supports | moderate | Prospective single-centre cohort of 300 patients who had a laparoscopic sleeve gastrectomy in 2013-14, with 193 (64.3%) followed for 10 years. Mean BMI fell from 42.54 at baseline to 29.15 at one year; regain began after three years and left a mean BMI of 31.89 at 10 years, so about 10.6 BMI units of the loss was still held a decade on. Half the patients (51.5%) kept at least 25% of their excess weight off. There was no comparison group, and a third of those operated on were not followed to 10 years. |
| Sjöström L 2013 · J Intern Med | observational | supports | moderate | A review of the Swedish Obese Subjects study's own results published between 2004 and 2012: 2,010 obese adults who had bariatric surgery and 2,037 contemporaneously matched controls on usual care. Mean weight change was -23% at 2 years and -17%, -16% and -18% at 10, 15 and 20 years in the surgery group, against 0%, 1%, -1% and -1% in controls. Surgery was also linked to lower overall mortality (adjusted HR 0.71, 95% CI 0.54-0.92) and fewer cases of diabetes, heart attack, stroke and cancer. These weight figures restate earlier SOS reports rather than adding new follow-up. |
| Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Capristo E, Chamseddine G, Bornstein SR, Rubino F 2021 · Lancet | RCT | supports | high | Ten-year follow-up of a randomised trial in Rome: 60 people with type 2 diabetes and a body-mass index of 35 or more were assigned to medical therapy, Roux-en-Y gastric bypass or biliopancreatic diversion, and 57 were reassessed a decade later. The outcomes it reports are diabetes ones: 15 of the 40 surgically treated patients (37.5%) in remission across the ten years against 5.5% on medical therapy, and fewer diabetes-related complications after surgery (relative risk 0.07, 95% CI 0.01-0.48). No weight or body-mass-index result is reported. |
| Noel P, Cazeres C, Lutfi RE, Nocca D 2026 · J Laparoendosc Adv Surg Tech A | observational | supports | moderate | A narrative review of PubMed, MEDLINE and Cochrane collecting studies that reported outcomes 10 years or more after five bariatric operations. Weighted mean total weight loss at 10 years ranged from 24.4% for sleeve gastrectomy to about 40% for biliopancreatic diversion with duodenal switch. The SLEEVEPASS randomised trial found more weight lost with Roux-en-Y gastric bypass than with sleeve (excess weight loss 51.9% versus 43.5%, P<.05); one-anastomosis gastric bypass reached 64.1% and SADI-S 80% at 10 years. The authors conclude all five procedures give durable weight loss at 10+ years. |
| Salama AF, Yahmadi A, El Baba H, Baazaoui J, Gibreal K, Bougmiza M, Al Kuwari M 2026 · Surg Endosc | observational | supports | moderate | In 105 adults in Qatar whose sleeve gastrectomy had failed, the weight lost after a second, revisional operation held for seven years: total weight loss was 21.6% at one year and 19.6% at seven with SADI-S, and 15.0% then 13.2% with gastric bypass (p = 0.01 at seven years), BMI down 8.9 versus 5.4 points. Reflux resolved far more often after bypass, and low iron, vitamin D, zinc, folate or B12 persisted in both groups. Retrospective and single-centre, and patients who did not attend follow-up were excluded. |
| Bocchinfuso S, Sample JW, Jawhar N, Abedalqader T, El Ghazal N, Laplante S, Mehta K, Ghanem OM 2026 · Surg Laparosc Endosc Percutan Tech | observational | supports | low | Single-centre retrospective chart review at Mayo Clinic of 360 adults (86% female, mean age 50) who had a first reoperative bariatric operation between 2000 and 2024. Conversion to Roux-en-Y gastric bypass was commonest (49%), and weight recidivism the commonest reason for reoperating (37%). The measured outcomes are surgical: length of stay, blood loss, operating time, complications, readmission, reintervention, one procedure-related death. No weight, BMI or percent-weight-loss figure is reported, so the closing phrase about durable long-term weight loss rests on no number the paper gives. |
| Athanasopoulou M, Paltoglou G, Charmandari E 2026 · Hormones (Athens) | observational | supports | moderate | A PRISMA systematic review of 39 studies in adolescents aged 12-19 - 33 observational studies, three randomised trials and three clinical trials, 7,375 participants - in which 'data were synthesized qualitatively'. It concludes that 'bariatric surgery is an effective intervention for severe pediatric obesity, achieving significant weight reduction and metabolic improvements', with gastric banding giving 'less durable weight loss' and sleeve gastrectomy possibly 'less effective for diabetes remission'. No pooled figure is given for how much weight is lost, or over how long. |
| Courcoulas AP, Patti ME, Hu B, Arterburn DE, Simonson DC, Gourash WF, Jakicic JM, Vernon AH, Beck GJ, Schauer PR, Kashyap SR, Aminian A, Cummings DE, Kirwan JP 2024 · JAMA | RCT | supports | high | Pooled RCT (ARMMS-T2D) 7-12yr: surgery sustained ~19.3% weight loss vs ~10.8% medical at 7yr. |
| Buzga M, Machytka E, Ryou M, Svagera Z, Janochova K, Machackova J, Kral J, Horka V, Haluzik M, Thompson CC 2026 · Endoscopy International Open | observational | supports | low | First-in-human single-arm pilot: 10 adults with obesity (mean BMI 41.1), 4 with type 2 diabetes and 3 with prediabetes, given a partial jejunal-ileal bypass created by magnets delivered through endoscopes, with laparoscopic ports placed in every patient. At 36 months mean weight had fallen from 120.9 to 101.9 kg - 15.9% of total body weight (SD 13.7) and 43.2% of excess weight (SD 41.8), a spread nearly as wide as the average. HbA1c in the four diabetic patients went 7.8% to 5.9%. No control group; one internal hernia needed surgery, one trocar injury, 80% B12-deficient by 3 years. |
| Dallal RM, Streitfeld N, Haddadin ZM, Beekley AC, Tatarian T, Neff MA, Kyrillos JV, Das A, Trang AC 2026 · Surg Obes Relat Dis | observational | supports | moderate | In 1,314 consecutive Roux-en-Y gastric bypass patients at one community teaching hospital (operated 2006-2011, average follow-up 11.7 years, 82% with data at 10 years), total body weight loss averaged 35% at 2 years and 28.5% at 10 years. At 10 years only 1.8% of patients weighed more than they had before surgery. Higher starting weight, younger age and Caucasian race went with greater weight loss. Weight was measured before any GLP-1 drug was started. Single-centre retrospective series with no non-surgical comparison group for weight. |
| Hamed H, Tarek M, Gado W, Eldesoky M, Mahdy T 2026 · Obes Surg | observational | supports | moderate | Retrospective single-centre cohort: 95 patients given a single-anastomosis sleeve ileal (SASI) bypass, 89 followed to 10 years, no control group. Weight bottomed near 90% excess-weight-loss (BMI 27.5) by year two, then drifted back to 58.6% (BMI 30.8) at 10 years, with 74 patients still holding 50% or more. Of the 51 diabetic before surgery, 45 (88%) were off medication with normal glucose at 10 years. Outcome tracked technique: the earliest 250 cm configuration gave 30.2% EWL and 6 of 15 needed reversal for malnutrition; the 350 cm version gave 62.5% EWL and no reversals. |
| Kim Y, Kim KH, Lee SH, Moon Y, Oh Y, Seo KW 2026 · J Metab Bariatr Surg | observational | supports | low | Narrative review of long-term outcomes after metabolic and bariatric surgery. It reports sustained weight loss with durable improvement in type 2 diabetes, hypertension and dyslipidemia: in ARMMS-T2D diabetes remission after surgery was 18.2% at 7 years and 12.7% at 12 years, versus 6.2% falling to 0.0% with medical/lifestyle care; Teen-LABS adolescents lost 27% of body weight at 3 years. Late costs are reported alongside — transfusion for anemia 12.0% vs 3.1% and fractures 13.3% vs 5.2% through 12 years. The review pools no data of its own. |
| Susmallian S, Babis I, Raziel A 2026 · Diabetes Metab Res Rev | observational | supports | moderate | Retrospective single-centre cohort of 60 Israeli patients with a BMI of 60 or more operated on between 2008 and 2019 (mean baseline BMI 63.8; 23% were revisional operations). Mean total weight loss was 38.0% within 2 years, 37.4% at 2-5 years, 22.4% at 5-10 years and 19.4% beyond 10 years (p=0.054); at the last follow-up, a mean of 72 months, mean BMI was 45.1 and mean total weight loss 29.4%. About half the peak loss came back, yet a large loss was still held a decade on. There was no comparison group, and the abstract does not say how many patients reached each follow-up window. |
| Czerwińska A, Karpińska I, Dowgiałło-Gornowicz N, Jaworski P, Major P, BARI-10-POL Collaborative Study Group 2026 · Sci Rep | observational | supports | moderate | Retrospective multicenter cohort, 89 patients BMI≥50 with ≥10y follow-up (mean 11.1y); 77.5% reached ≥20%TWL, 58.4% reached ≥50%EWL, though revisional surgery for regain more frequent (43.8%) in the highest-BMI group. |
| Nor Hanipah Z, Boyer LM, Queen KE, Staiano AE, Drews KL, Albaugh VL, Katzmarzyk PT, Schauer PR 2026 · Obesity Surgery | observational | supports | low | Single-centre retrospective series of 76 patients aged 10-25 (mean age 22.6, mean BMI 49.4, 80% female) operated on in Baton Rouge, Louisiana between 2020 and 2025; 59% had a sleeve gastrectomy. Mean total weight loss was 29.4% at 1 year, 29.7% at 2 years and 32.0% at 3-5 years, so weight did not creep back over the period watched - but only 69%, 57% and 50% of the cohort had data at those points, mean follow-up was 16 months, and the spread was wide (SD 9.9 to 13.9). No comparison group. |
| Sjöström L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden Å, Bouchard C, Carlsson B, Karason K, Lönroth H, Näslund I, Sjöström E, Taube M, Wedel H, Svensson PA, Sjöholm K, Carlsson LM 2014 · JAMA | observational | supports | high | This report from the Swedish Obese Subjects cohort followed 343 surgery and 260 usual-care patients who had type 2 diabetes at baseline, and measured diabetes remission and vascular complications: remission 72.3% versus 16.4% at 2 years and 30.4% versus 6.5% at 15 years, macrovascular complications 31.7 versus 44.2 per 1000 person-years and microvascular 20.6 versus 41.8. It presents no weight-change result; the cohort's weight-loss findings are reported in other Swedish Obese Subjects papers. |
| Galvan JAA, Loo GH, Kosai NR, Yeong CH, Chinna K, Nordin RB, Lee KK, Mustafa N 2026 · Journal of Multidisciplinary Healthcare | observational | supports | moderate | Retrospective single-centre cohort of 180 Malaysian adults with obesity and type 2 diabetes who had sleeve gastrectomy or gastric bypass in 2014-2016, followed 5 years. Mean BMI fell from 49.3 to 25.3 kg/m2 (p<0.001), with the reduction holding from year 2 through year 5; among the 153 patients still followed at 5 years, 127 (83%) were below a BMI of 30. Complications were rare (2.2%, all minor). There was no comparison group, and the authors state that weight regain and re-operations were not systematically recorded. |
| Parzer V, Taube M, Ludvik B, Peltonen M, Svensson PA, Brix JM, Sjöholm K 2024 · Obes Facts | observational | supports | moderate | Swedish Obese Subjects study: 2,504 adults with obesity, 1,370 who had bariatric surgery and 1,134 matched usual-care controls, followed 10 years with measured weight. Mean BMI in the surgery group fell from 42.1 to 31.3 at one year and stood at 34.9 at ten years, while controls went from 39.7 to 40.7. Between year 1 and year 10, 747 of the 1,370 surgical patients regained at least 10% of their one-year weight, yet even those regainers averaged BMI 37.2 at ten years against a 42.0 baseline. Surgery was chosen by patients, not randomised. |
| Papadia FS, Adami GF, Roscelli C, Cassano M, De Cian O 2026 · Ann Surg | observational | supports | moderate | Follow-up of the first 85 patients to undergo biliopancreatic diversion in Genoa (1976-1979), the longest reported follow-up of any bariatric operation. Percent total weight loss rose from 31% at 1 year to 39% beyond 40 years, and remission of type 2 diabetes was described as universal and durable. The long-term figure is measured only in survivors - 53.7% of the cohort were alive at 40 years - and the paper does not report how many patients contributed it. The cost was steep: any nutritional complication rose from 13% at 1 year to 86% beyond 40 years, and 20% (17/85) needed revision surgery. |
| Konttinen H, Sjöholm K, Carlsson LMS, Peltonen M, Svensson PA 2024 · Int J Obes | observational | supports | moderate | This 15-year report from the Swedish Obese Subjects study followed 2,007 adults who had bariatric surgery and 2,040 matched adults on usual obesity care, and measured six quality-of-life scales - weight was not an endpoint. It notes in passing that average BMI fell about 15% from baseline to 15 years in the surgery group while controls showed no major change. Obesity-related problems improved far more with surgery (15-year change -29.0 vs -8.6 points, effect size 0.82); other quality-of-life differences were small. Surgery was chosen by the patient, not randomly assigned. |
| Tan SYT, Liang TR, Chua JKL, Tan HC, Ho ETL, Kovalik JP, Goh OQM, Lim CH, Eng AKH, Chan WH, Lim EKW, Tan JTH, Foo AX, Lee PC 2026 · J Clin Med | observational | supports | low | Retrospective single-centre cohort of 184 adults in Singapore with a BMI of 50 or above (mean 55.3) who had sleeve gastrectomy (164) or gastric bypass (20) between 2008 and 2022. Average total weight loss was 27.4% at 12 months and 27.1% at 24 months, so the loss held rather than rebounded, and was similar for the two operations. Follow-up was incomplete, and those figures come from 125 patients at 12 months and 94 at 24 months, 68% and 51% of the cohort. The study stops at two years and reports nothing about weight loss beyond that. |
| Zhong W, Chen L, Huang Y, Zhu D, Tang W, Ouyang Y, Chu X, Feng W 2026 · Frontiers in Endocrinology | observational | supports | low | Retrospective single-centre Chinese cohort: 102 adults who had sleeve gastrectomy or gastric bypass (26 with BMI 27.5-32.5, 76 with BMI 32.5 or above, matched on age, sex and follow-up length), followed a mean 5.0 and 4.4 years. Weight fell fast in the first year then held steady: total weight loss averaged 18.0% in the mild-obesity group vs 27.3% in the higher-BMI group (adjusted difference -9.3%, 95% CI -14.0 to -4.7), mean weight 83.2 to 68.2 kg and 108.5 to 78.4 kg. The four-part metabolic target was met by 30.7% vs 27.6%. No non-surgical comparison group. |
| Scheen AJ, Letiexhe M, Rorive M, De Flines J, Luyckx FH, Desaive C 2005 · Rev Med Liege | observational | supports | moderate | A French journal's 'clinical study of the month' column summarising, for its readers, the 10-year results of the Swedish Obese Subjects Study as they were published in the New England Journal of Medicine. It reports no data of its own. The figures it relays: 627 conventionally treated controls versus 641 surgery patients (banding 156, vertical banded gastroplasty 451, gastric bypass 34), 74.5% attending the 10-year examination; at 10 years body weight was up 1.6% in controls and down 16.1% after surgery (p<0.001), waist circumference +2.8% versus -10.1%. |
| Rao RS, Hogan G, Rao A, Sweeny A, Mehta M 2026 · Endocrine | observational | supports | low | Retrospective single-surgeon Australian series of adults with type 1 diabetes and obesity who had SADI-S bariatric surgery between 2017 and 2023. Twelve were operated on; three moved overseas and one gave only baseline data, leaving eight analysed. Mean weight fell from 108 kg to 73 kg by 60 months, about 34% of body weight, and BMI from 38.6 to 26.4 kg/m2; HbA1c went from 8.4% to 7.1% and daily insulin from 42 to 23 units. There was no comparison group, and only two patients had complete five-year glucose-monitoring records. |
| Endo Y, Takayama H, Miyoshino W, Nakamura S, Nagasawa Y, Kawamura M, Kawano Y, Masuda T, Hirashita T, Ozeki Y, Masaki T, Shibata H, Inomata M 2026 · Annals of Gastroenterological Surgery | observational | supports | moderate | Retrospective single-center Japanese cohort: 28 consecutive patients who had laparoscopic adjustable gastric banding between 2005 and 2010, followed for up to 15 years. Mean excess weight loss was 49% at 1 year, 62% at 5 years, 64% at 10 years and 59% at 15 years, which the authors read as sustained long-term weight reduction despite partial regain. Diabetes, hypertension and dyslipidaemia recurred after 5-10 years, and 7 of 28 patients (25%) needed reoperation, mainly for device complications or insufficient weight loss. |
| Papadia FS 2026 · Obes Surg | observational | supports | moderate | A critical review of hypoabsorptive bariatric procedures, drawing on registry analyses, comparative studies and cohorts followed up to 30 years. At five years these procedures gave 40.6% total weight loss against 33.8% for gastric bypass, with 92.8% diabetes remission. The durability came at a cost: cumulative reoperation reached 37% at 10 years, and nutritional problems affected more than 80% of patients in cohorts that, the author notes, often include people operated on with historical techniques. Complications appeared earlier in older, lower-BMI and sicker patients. |
| Gant L, Myerson M 2026 · J Clin Lipidol | observational | supports | moderate | Narrative review of recent trials and techniques; concludes MBS 'consistently achieves superior and sustained weight loss compared with nonsurgical strategies' with durable comorbidity resolution and reduced major cardiovascular events. |
| Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, Singh RP, Pothier CE, Nissen SE, Kashyap SR, STAMPEDE Investigators 2017 · N Engl J Med | RCT | supports | high | In the STAMPEDE trial, 150 people with type 2 diabetes and a BMI of 27 to 43 were randomly assigned to intensive medical therapy alone or the same therapy plus gastric bypass or sleeve gastrectomy, and 134 were reassessed 5 years later. Body weight was down 23% after bypass (49 patients) and 19% after sleeve gastrectomy (47 patients), against 5% on medical therapy alone (38 patients). Bypass lost more than sleeve (P=0.01), and excess weight gain occurred in 19% of the medical group but in nobody in either surgical group. |
| Gosher N, Globus I, Rosenberg A, Keidar A, Eldar SM, Abu-Abeid A 2026 · Obes Surg | observational | supports | moderate | Israel's mandatory national bariatric registry, all 33 centres: 460 adolescents under 18 (mean age 16.9, mean BMI 46.4) operated on in 2017-2024, 403 of them sleeve gastrectomy. For sleeve alone, mean excess-weight loss was 56.3% at 6 months, peaked at 70.7% at 2 years, dipped to 66.0% at 3 and stood at 68.5% at 4. Across the whole cohort, total weight loss was 25.0% at 6 months, 30.9% at 1 year and 29.9% at 4 years - but that last figure comes from only 90 of the 460, and dietitian follow-up fell from 47.6% to 14.5%. Sixteen were re-operated as adults, 13 for weight regain. |
| Mendes C, Carvalho M, Gregorio J, Palmeira A 2026 · Obes Surg | observational | supports | low | Retrospective single-centre cohort of 81 Portuguese women followed five years after Roux-en-Y gastric bypass. Mean weight fell from 112 to 74.9 kg at one year and stood at 77.7 kg at five years; BMI went 44.8 to 27.7 to 30.8 kg/m2. Total weight loss was 33.6% at one year and still 30.6% at five, so most of the loss held. But 57.1% of the women gained more than 5% back on their one-year weight, and the share below a BMI of 30 fell from 77.9% at one year to 49.4% at five. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.